Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes

Daisuke Hasegawa, Osamu Nishida

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Access to Document

@article{26c39385582348ec8dbeea4a97dfe16d,

title = "Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes",

author = "Daisuke Hasegawa and Osamu Nishida",

year = "2019",

month = jun,

day = "24",

doi = "10.1186/s13054-019-2521-7",

language = "English",

volume = "23",

pages = "231",

journal = "Critical Care",

issn = "1364-8535",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes

AU - Hasegawa, Daisuke

AU - Nishida, Osamu

PY - 2019/6/24

Y1 - 2019/6/24

UR - https://www.scopus.com/pages/publications/85068745150

U2 - 10.1186/s13054-019-2521-7

DO - 10.1186/s13054-019-2521-7

M3 - Letter

C2 - 31234901

AN - SCOPUS:85068745150

SN - 1364-8535

VL - 23

SP - 231

JO - Critical Care

JF - Critical Care

IS - 1

ER -